Healthcare
Sectors

EPP 7: Upscale Malaysia’s IVD Industry - Mediven & Olipro

  • GNI by 2020 (mil)
    RM30.9
  • Projected jobs by 2020
    60

EPP 7: Upscale Malaysia’s In-Vitro Diagnostic (IVD) Industry

In 2014, Olipro Biotechnology, a Bionexus status company that manufactures World Health Organisation-standard test kits in Malaysia also joined this EPP. The company is undertaking a project to manufacture its HIV 1/2 Rapid Test Kit which screens and detects HIV 1 & 2, and the Olipro BloodChek LF Kit that detects transfusion-transmissible infections during blood donations or screenings. The project is expected to contribute RM6.83 million in GNI, RM900,000 in investment and 38 new jobs.

  • Investment (mil)
    RM8.9


Highlights

  • Mediven continues to work with the respective authorities to ensure its medical devices comply with the necessary standards for the local and export markets.
  • Olipro is constructing a new manufacturing facility and in 2014, launched six new products. It has also expanded its market to Indonesia and Brunei.
2015/08/06
Photo Gallery

Status:
Work In Progress
Economic Transformation Programme
The ETP Transformation Story
The Economic Transformation Programme (ETP) is a comprehensive effort that will transform Malaysia into a high-income nation by 2020.
Copyright © 2013 Performance Management & Delivery Unit (PEMANDU)